Literature DB >> 22844210

Absence of Apo B R3500Q Mutation among Kelantanese Malays with Hyperlipidaemia.

W M Kyi1, M N Isa, F A Rashid, J M Osman, M A Mansur.   

Abstract

Familial defective apolipoprotein B-100 (FDB) is an autosomal dominant genetic disorder associated with hypercholesterolaemia and premature coronary heart disease. FDB is caused by mutations in and around the codon 3500 of the apolipoprotein B (apo B) gene. Apo B R3500Q mutation is the first apo B mutation known to be associated with FDB and it is the most frequently reported apo B mutation in several different populations. The objective of the present study was to determine the association of apo B R3500Q mutation with elevated plasma cholesterol concentration in Kelantanese population in which both hypercholesterolaemia and coronary heart disease are common. Sixty-two Malay subjects with hyperlipidaemia, attending the lipid clinic at Hospital Universiti Sains Malaysia, Kelantan, were selected for this study. The DNA samples were analysed for the presence of apo B R3500Q mutation by polymerase chain reaction-based restriction fragment analysis method using mutagenic primers. This mutation was not detected in the subjects selected for this study. Apo B R3500Q mutation does not appear to be a common cause of hypercholesterolaemia in Kelantanese Malays.

Entities:  

Keywords:  Familial defective apolipoprotein B-100; apo B mutations; hypercholesterolaemia

Year:  2000        PMID: 22844210      PMCID: PMC3406212     

Source DB:  PubMed          Journal:  Malays J Med Sci        ISSN: 1394-195X


  14 in total

1.  Using mutagenic polymerase chain reaction primers to detect carriers of familial defective apolipoprotein B-100.

Authors:  C Motti; H Funke; S Rust; A Dergunov; G Assmann
Journal:  Clin Chem       Date:  1991-10       Impact factor: 8.327

2.  Detecting familial defective apolipoprotein B-100: three molecular scanning methods compared.

Authors:  B G Henderson; P R Wenham; J P Ashby; G Blundell
Journal:  Clin Chem       Date:  1997-09       Impact factor: 8.327

3.  A simple salting out procedure for extracting DNA from human nucleated cells.

Authors:  S A Miller; D D Dykes; H F Polesky
Journal:  Nucleic Acids Res       Date:  1988-02-11       Impact factor: 16.971

4.  Familial defective apolipoprotein B-100: detection in the United Kingdom and Scandinavia, and clinical characteristics of ten cases.

Authors:  A Tybjaerg-Hansen; J Gallagher; J Vincent; R Houlston; P Talmud; A M Dunning; M Seed; A Hamsten; S E Humphries; N B Myant
Journal:  Atherosclerosis       Date:  1990-01       Impact factor: 5.162

5.  Familial defective apolipoprotein-B is rare in hypercholesterolaemic South African Afrikaners, coloureds and Indians.

Authors:  D C Rubinsztein; G A Coetzee; D R van der Westhuyzen; E Langenhoven; M J Kotze
Journal:  S Afr Med J       Date:  1995-05

6.  Absence of familial defective apolipoprotein B-100 in Japanese patients with familial hypercholesterolaemia.

Authors:  A Nohara; K Yagi; A Inazu; K Kajinami; J Koizumi; H Mabuchi
Journal:  Lancet       Date:  1995-06-03       Impact factor: 79.321

7.  Association between a specific apolipoprotein B mutation and familial defective apolipoprotein B-100.

Authors:  L F Soria; E H Ludwig; H R Clarke; G L Vega; S M Grundy; B J McCarthy
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

8.  New methods for rapid detection of low-density lipoprotein receptor and apolipoprotein B gene mutations causing familial hypercholesterolemia.

Authors:  A Minnich; M Roy; A Chamberland; J Lavigne; J Davignon
Journal:  Clin Biochem       Date:  1995-06       Impact factor: 3.281

9.  Absence of familial defective apolipoprotein B-100 in Finnish patients with elevated serum cholesterol.

Authors:  T Hämäläinen; A Palotie; K Aalto-Setälä; K Kontula; M J Tikkanen
Journal:  Atherosclerosis       Date:  1990-06       Impact factor: 5.162

10.  Detection of familial defective apolipoprotein B-100 among patients clinically diagnosed with heterozygous familial hypercholesterolemia in maritime Canada.

Authors:  B Morash; D L Guernsey; M H Tan; G Dempsey; B A Nassar
Journal:  Clin Biochem       Date:  1994-08       Impact factor: 3.281

View more
  1 in total

1.  Familial Hypercholesterolaemia in the Malaysian Community: Prevalence, Under-Detection and Under-Treatment.

Authors:  Yung-An Chua; Aimi Zafira Razman; Anis Safura Ramli; Noor Alicezah Mohd Kasim; Hapizah Nawawi
Journal:  J Atheroscler Thromb       Date:  2021-01-15       Impact factor: 4.928

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.